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Summary 
Heat-stable antigen (HSA) is a small, glycosyl phosphatidylinositol-anchored protein that can 
act as a costimulatory molecule for antigen-dependent activation of helper T  cells. In addition 
to being expressed on antigen-presenting B cells, HSA is also expressed during the initial stages 
of T  cell development in the thymus. HSA levels are very high on immature CD4-,  CD8- 
double negative thymocytes, but are reduced on CD4 § , CD8 + double positive cells undergoing 
selection  in  the  thymus,  and  are  entirely  eliminated  when  these  cells  differentiate  into 
immunologically competent CD4 + or CD8 § single positive T  cells. To examine the potential 
roles of this molecule in T cell development and selection, we generated transgenic mice in which 
HSA was highly expressed on all classes of thymocytes. The consequence of deregulated HSA 
expression was a pronounced reduction in the numbers of double positive and single positive 
thymocytes, whereas the numbers of their double negative precursors were largely unaffected. 
These results demonstrate that downregulation of HSA expression at the double positive stage 
is a critical event in thymocyte development. The depletion of thymocytes resulting from HSA 
overexpression begins at the same time as the onset of negative selection, suggesting that HSA 
may provide signals  that contribute to determining the efficiency of this process. 
H 
eat-stable antigen (HSA) 1 has recently been identified 
as an important costimulatory molecule for the activa- 
tion of murine Th cells (1, 2).  The expression of HSA on 
APCs provides a second signal, subordinate to that provided 
by MHC-presented peptide, which induces the activation and 
proliferation of antigen-specific Th cells. In the absence of 
this second signal,  which can also be provided by the B7 
costimulatory molecule independently of or in cooperation 
with HSA (3, 4), the interacting Th cell is driven into an 
inactivated, nonproliferating state. 
One type of APC that expresses HSA is the B cell. Levels 
of HSA expression vary both during B cell development and 
among functional classes of mature B cells. The earliest B 
cell precursors identifiable in bone marrow are HSA-  (5). 
Their immediate progeny acquire expression of moderate to 
high levels of HSA, with the highest levels being found on 
cycling pro-B cells (5). Pre-B cells with rearranged immuno- 
globulin  genes and  most  mature primary B  cells  express 
moderate levels of HSA (5-9).  However, the minor subset 
1 Abbreviations used in this~per: DN, double  negative;  DP, double  positive; 
hGH, human  growth hormone;  HFN, HBSS/fetal  bovine serum/sodium 
azide; HSA, heat-stable antigen. 
of virginal B cells that can differentiate into memory cells 
after antigen exposure has only very low levels of HSA, as 
do circulating memory B cells (8,  9).  It is not yet known 
whether the regulated expression of HSA on B cells deter- 
mines their functional capabilities as T cell-activating or -sup- 
pressing APCs. 
HSA is also expressed during the initial stages of T  cell 
development (10-14).  HSA is found on the earliest T  cell 
precursors that have been identified in the thymus (15, 16), 
and  expression  continues  at  high  levels  throughout  the 
CD4-  CDS-  double negative (DN) stage (10, 12). A reduc- 
tion in the level of HSA expression occurs with the differen- 
tiation of DN thymocytes into CD4 + CD8 + double posi- 
tive (DP) thymocytes (10, 11). Subsequent maturation of the 
DP thymocytes into CD4 + or CD8 §  single positive (SP) 
thymocytes is accompanied by loss of HSA expression, and 
HSA remains absent from these cells after they have migrated 
from the thymus as functional T  cells (6,  11). 
The loss of HSA expression before the emigration of ma- 
tured T cells from the thymus is perhaps to be expected, be- 
cause the presence of HSA on T  cells might interfere with 
their recognition of or response to costimulating HSA pre- 
sented by APCs. However, it is not obvious why HSA should 
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As an initial step  in determining the function of HSA in 
thymocyte development, we have generated transgenic mice 
in which thymocytes at all stages express high levels of liSA. 
The severe depletion of all thymocytes beyond the DN stage 
that occurs in these transgenic mice points to an important 
role for downregulation of HSA expression in the ability of 
thymocytes to survive selection and differentiate into mature 
T  cells. 
Materials and Methods 
Construction of the HSA Transgene.  The pLIT2 vector was de- 
rived from p1017 (17), with the lck proximal promoter downstream 
of the StuI site at about  - 1,000 bp replaced by the Ig # enhancer 
and TCR/3 promoter of pJFE#VflMT  (Jirik, F., University of 
British Columbia, unpublished results). A frame-shift was intro- 
duced into the human growth hormone (hGH) coding region at 
the BglII site to ensure that a functional hGH protein could not 
be expressed from the pLIT2 vector. The 270 bp HinFI fragment 
of pSL87c4 (18) containing the complete coding region of HSA 
was inserted between the promoter and the introns and polyade- 
nylation site of the hGH gene (19) to generate the transgene con- 
struct pLIT2-HSA. 
Generation of Transgenic  Mice.  The 7,100-bp transgene portion 
of pLIT2-HSA was released by SstlI digestion, purified by agarose 
gel electrophoresis, and injected into the pronuclei of (C57BL/6J 
x  C3H)F2 hybrid zygotes. Pups resulting from transplantation of 
injected zygotes into pseudopregnant females were analyzed for 
the presence of the transgene by Southern blot analysis  of tail DNA 
hybridized with a 2.1-kb hGH probe or by PCK analysis using 
oligonucleotide primers flanking the HSA-hGH junction in the 
transgene. 
Analysis of Transc@ts.  Total  cellular RNA was purified from 
tissues as described (20), and separated by electrophoresis through 
agarose gels containing formaldehyde.  After transfer to nylon mem- 
branes (ZetaProbe, BioRad, Richmond, CA) mRNAs were detected 
by hybridization as described (21), using DNA probes labeled  with 
32p by random priming (22). The hGH probe included all hGH 
sequences within the pLIT2 vector, encompassing the entire hGH 
coding region and introns (19). The HSA probe was the 270-bp 
HinFI fragment of pSL87c4 (18). 
Flow Cytometric  Analysis of  Protein  Expression.  Cells  were released 
from tissues by disruption through a fine steel mesh and washed 
in HBSS containing 5% fetal bovine serum and 0.1% sodium azide 
(HFN). Staining with primary and secondary antibodies was done 
on ice in HFN. After washing in HFN, cells were analyzed on 
FACScan  |  or FACStar Plus  |  flow cytometers (Becton Dickinson 
& Co., Mountain View, CA). HSA was detected with purified and 
biotinylated mAb M1/69 (6). FITC-labeled CD3, CD4, and CD8 
mAb were from Boehringer  Mannheim (Indianapolis,  IN), whereas 
the biotinylated CD8 mAb, PE-labelled CD4,  and all anti-TCR 
mAb were from Pharmingen. The anti-IL-2  receptor cr mAb was 
from the 7D4 hybridoma  (American  Type  Culture Collection,  Kock- 
ville, MD). 
CD3 Stimulation and Proliferation Assay.  CD4 + or CD8 + cells 
from thymus or axillary and inguinal lymph nodes were purified 
by sorting on the FACStar  |  flow cytometer. 5  x  104 cells were 
incubated in RPMI medium containing 50 #M 2-ME and 5% fetal 
bovine serum, in microtiter plate wells that had been coated with 
CD3  mAb  (a  generous gift from J.  Bluestone, University of 
Chicago, Chicago, IL). After 66 h, 1 #Ci of [3H]thymidine  was 
added to each well for a 6-h pulse-labeling period. The cells were 
then washed, and incorporated  radioactivity  was measured  by liquid 
scintillation counting. 
Results 
Generation of Transgenic Mice Overexpressing  lISA in Thymo- 
cytes.  To achieve high levels of  expression of  liSA throughout 
all stages of thymocyte  development, a cDNA encoding HSA 
was fused to a transcription-activating complex consisting 
of an immunoglobulin # enhancer and the TCR/3 promoter 
(Fig. 1). The transgene also contained a region of the lck gene 
upstream of its proximal promoter (23), because this region 
was suspected  to have an expression-enhancing function in 
thymocytes of transgenic mice. 
Two transgenic mice were produced by injection of the 
HSA transgene into fertilized zygotes. One of the transgenic 
mice had about four integrated copies of the transgene, and 
was sterile  (LIT2-20). The other transgenic mouse had an 
estimated 80 copies of the transgene and was fertile, serving 
as the founder of a breeding line (LIT2-37).  Its offspring were 
crossbred  to generate mice that were homozygous for the 
transgene locus (LIT2-37 x 37). These HSA transgenic mice 
developed normally and were healthy in a pathogen-free en- 
vironment. 
Expression of the HSA Transgene.  The LIT2-37 transgenic 
line expressed  the HSA transgene mRNA (specifically de- 
tected by hybridization with a hGH probe, Fig. 2 A) in thymic 
tissue at levels that were considerably higher than those of 
the endogenous HSA gene (detected along with the trans- 
gene transcript by an HSA probe, Fig. 2 B). Transgene mKNA 
levels were about twice as high in LIT2-37 x 37 homozygous 
transgenic mice versus LIT2-37 heterozygous transgenic mice. 
mRNAs from the transgene were found at moderate levels 
in lymph nodes, spleen,  and bone marrow, and at very low 
levels in brain and heart (Fig.  2). 
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Figure  1.  Structure  of the HSA 
transgene. The pLIT2 vector con- 
tains the complete  coding  region  of 
the HSA cDNA. Its transcription 
is driven  by the promoter  from the 
TCK fl gene, coupled  to the # en- 
hancer from the Ig H chain gene. 
A large  fragment  of the kk gene  up- 
stream of the proximal promoter is also present. Sequences from the hGH gene, including  splice sites and a polyadenylation  signal, are downstream 
of the HSA coding region and are included in the primary transcript. 
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samples of total cellular RNA from the indicated tissues of nontransgenic 
mice (Normal), heterozygous  (LIT-37), or homozygous  (LIT-37x37)  trans- 
genic mice were analyzed  by Northern blot for the presence  of transcripts 
derived  from the HSA transgene (detected  by the hGH as well as the HSA 
probes) and the endogenous HSA gene (detected  by the HSA probe only). 
The small transcripts detected in some tissues by the hGH probe only 
are probably derived  from the endogenous mouse growth hormone gene. 
Flow  cytometry was  used to compare the expression of 
HSA protein on subpopulations of thymocytes in the LIT2- 
37 ￿  37 transgenic mice versus nontransgenic mice from the 
same litters  (Fig.  3).  HSA was  expressed at  high  levels on 
most DN  thymocytes of the nontransgenic mice, and these 
levels were only slightly elevated in the DN thymocytes from 
the transgenic mice. HSA expression was at intermediate levels 
in almost  all DP thymocytes of nontransgenic mice, but in 
the transgenic mice a majority of DP thymocytes had high 
HSA levels, equivalent to those seen in DN thymocytes. Simi- 
larly, HSA levels were at high or intermediate levels in most 
SP thymocytes of transgenic mice, whereas in nontransgenic 
mice, SP thymocytes had only intermediate to nil HSA ex- 
pression. Thus, in the transgenic mice, HSA expression was 
not significantly altered in DN thymocytes but was elevated 
above normal levels in DP thymocytes and extended to SP 
thymocytes that  normally  lack expression. 
Depletion of Specific Thymocyte Subpopulations  in lISA  Trans- 
genic Mice.  All of the HSA transgenic mice had abnormally 
small  thymuses.  This was particularly obvious in  the mice 
that were homozygous for the transgene locus. Histological 
staining  showed that  the  thymic medullary regions  of the 
transgenic  mice  were  sparsely  populated  and  the  cortical 
regions were indistinct and very thin relative to those of normal 
mice.  The thymuses  of homozygous HSA  transgenic  mice 
contained about one tenth the number of total thymocytes 
as did those of nontransgenic littermates (Table 1). This was 
due to a 10-20-fold depletion of both the DP and SP popula- 
tions,  which  normally constitute  almost  all of the cells in 
the  thymus  (Fig.  4,  Table  1). 
In striking contrast to the loss of most DP and SP thymo- 
cytes, the numbers of DN thymocytes were not significantly 
altered in the transgenic mice (Table 1). As a result, DN cells 
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Figure 3.  Expression of HSA on thymocyte subpopula- 
tions in normal and HSA transgenic mice. Total thymocytes 
from a 4-wk-old LIT2-37  x 37 homozygous  transgenic  mouse 
and its normal, nontransgenic  littermate  (Control)  were stained 
with FITC-conjugated  CD4, PE-conjugated  CDS, biotinylated 
M1/69 (anti-HSA) mAb, and CyS-streptavidin,  and analyzed 
by flow cytometry. The numbers above the histograms indi- 
cate the percentages  of  cells expressing  nil, low, or high levels 
of HSA. 
179  Hough et al. Table  1.  Thymocyte  Subpopulations in Normal and lISA 
Transgenic Mice 
Cell number  x  10  6 
Thymocyte  Cell number  ratio 
subpopulation  Normal  Transgenic  Transgenic/Normal 
Total  thymocytes  240  22  0.09 
CD4- CD8-  9.6  7.0  0.70 
CD4 § CD8 +  180  11  0.06 
CD4 § CD8-  31  2.6  0.08 
CD4- CD8 +  14  0.7  0.05 
IL-2R +  2.4  2.9  1.20 
Thymocytes from a 9-wk-old LIT2-37 x 37 homozygous  transgenic mouse 
and its normal,  nontransgenic  littermate were stained with FITC- or PE- 
conjugated mAb directed against the indicated antigens and analyzed by 
flow cytometry. Cell numbers were derived from direct counts of all cells 
freed from the thymus by disruption through a fine steel mesh. The trans- 
genic/normal cell number ratio indicates the degree of depletion  of each 
population in the transgenic  mice. 
constitute about 30% of thymocytes in the HSA transgenic 
mice, as opposed to 4% in the nontransgenic mice (Fig.  4). 
The DN population of thymocytes is heterogeneous, being 
composed of both immature  and mature T  cell types. DN 
thymocytes that express IL-2 receptor and that do not have 
detectable TCR on their surfaces are at an early stage in de- 
velopment and serve as precursors for DP cells (24). DN cells 
with  this immature phenotype were not depleted at all in 
the transgenic mice (Table  1). The DN population also in- 
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Figure  4.  Thymocyte subpopulations  in normal and HSA transgenic 
mice. Total thymocytes from a 9-wk-old LIT2-37 x 37 homozygous trans- 
genie mouse and its nontransgenic littermate (Control), a 12-wk-old LIT2-37 
heterozygous transgenic mouse, and the 25-wk-old LIT2-20 founder trans- 
genic mouse were stained  with FITC-conjugated CD4 mAb and  PE- 
conjugated CD8 mAb, and analyzed by flow cytometry. Numbers in quad- 
rants  indicate  the percentage  of the total population. 
cludes minor subsets of thymocytes that already express ei- 
ther  otB-TCR or 3'8-TCR.  DN cells  expressing crB-TCR 
are functionally mature and appear to have developed from 
TCtL-  DN precursors via an  intermediate  stage that  may 
have expressed at least CDS, and possibly CD4 as well (25, 
26). These ot/3-TCR + DN cells were highly depleted in the 
transgenic mice, to an extent equivalent to the depletion of 
the DP and SP cells (Fig. 5). In contrast, the DN thymocytes 
expressing yS-TCR were at normal levels in the HSA trans- 
genic mice. This is compatible with the onset of the depleting 
effects of HSA overexpression occurring at the DN to DP 
transition,  because the 78-TCR and c~B-TCR lineages di- 
verge before this  point  (27),  and  the "yS-TCR expressing 
thymocytes do not appear to pass through a DP stage before 
their  maturation  (28). 
There was a small but significant decrease in the average 
levels of expression of o08-TCR in the DP cells of the trans- 
genic versus normal mice (Fig.  6). The decline in CD3 ex- 
pression in this population was even more pronounced (Fig. 
6), indicating that there are many DP cells in the transgenic 
mice that express low levels of ot~-TCR but virtually no CD3. 
Most SP cells from the transgenic mice expressed both otB- 
TCR and CD3 at levels that were only slightly reduced from 
those on SP cells of normal mice (Fig. 6). However, the sub- 
populations  of SP cells  lacking TCR and CD3  expression 
were considerably more abundant in the transgenic mice, par- 
ticularly among  the CD4 + cells. 
The degree of depletion of DP and SP thymocytes in the 
transgenic mice was correlated with the level of HSA expres- 
sion attained,  as mice heterozygous for the transgene had a 
less severe phenotype than did their homozygous littermates, 
with only a threefold reduction in the numbers of DP and 
SP thymocytes (Fig. 4). Conversely, the sterile founder trans- 
genic mouse, which had very high levels of HSA expression 
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Figure  5.  3'8- and ot~8-TCR expressing DN thymocytes in normal and 
HSA transgenic  mice. Total thymocytes from an 8-wk-old  LIT2-37x37 
homozygous transgenic mouse and its nontransgenic  littermate (Control) 
were  stained  with  FITC-conjugated  CD4  and  CD8  mAb,  and  PE- 
conjugated  anti-',/~-TC1L or anti-~/3-TCtL mAb and analyzed by flow 
cytometry.  DP and SP cells were excluded from the analysis by gating 
on the basis of CD4 and/or CD8 expression. 
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in thymocytes, had an almost complete ablation of the DP 
thymocyte population  (LIT2-20,  Fig.  4). 
Mature T  Cell Populations in lISA Transgenic Mice.  Periph- 
eral CD8 + T  cells in lymph nodes and spleen were reduced 
about  10-fold in the  HSA transgenic versus  nontransgenic 
mice (Fig. 7). This may simply reflect their reduced output 
from the thymus, as it is in proportion to the depletion of 
CD8 § SP thymocytes in the transgenic mice. However, the 
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Figure  7.  T cell subpopulations in lymph nodes and spleens of normal 
and HSA transgenic mice. Total axillary and inguinal lymph node cells 
or spleen cells from a 9-wk-old  LIT2-37  x 37 homozygous  transgenic mouse 
and  its  nontransgenic littermate  (Control) were stained with  FITC- 
conjugated CD4 mAb and PE-conjugated CD8 mAb, and analyzed by 
flow cytometry. Numbers in quadrants indicate the percentage  of the total 
population. 
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Figure 6.  Expression  of  CD3 and ctB-TCR 
on thymocytes  of normal and HSA transgenic 
mice.  Total thymocytes from  a  9-wk-old 
LIT2-37x37  homozygous transgenic mouse 
and its nontransgenic littermate (Control) were 
stained  with  PE-conjugated CD4,  FITC- 
conjugated CD3, or anti-oe/3-TCR  mAb, and 
biotinylated CD8 mAb followed  by allophyco- 
cyanin-conjugated  streptavidin,  and  then 
analyzed by flow cytometry. The  numbers 
above the histograms indicate the percentages 
of cells expressing nil, low, or high levels of 
CD3 or ct/B-TCR. 
reduction in numbers of CD4 + peripheral  T  cells was not 
as dramatic and was proportionately less than the reduction 
in  the  numbers  of their  CD4 +  SP  thymocyte precursors 
(Fig.  7).  This implies  that  there was a  selective expansion 
or survival of CD4 + versus  CD8 +  T  cells  after  their  exit 
from the  thymus. 
CD4 § and CD8 + SP T  cells from lymph nodes of liSA 
transgenic mice had normal proliferative responses to CD3 
stimulation (Table 2), as did SP thymocytes. This result indi- 
Table  2.  Proliferative Responses of SP Thymocytes and T  Cells 
to CD3 Stimulation 
Thymidine incorporation 
Normal  Transgenic 
Cpm 
Thymocytes  CD4 +  57,121  _+  4,467  29,563  _+  4,033 
CD8 §  80,465  +  1,396  85,533  _+  8,574 
Lymph node 
T  cells  CD4 §  14,450  +  2,997  28,121  _+ 3,526 
CD8*  99,573  _+  6,910  53,245  -+  4,595 
CD4 + and CD8 + SP cells were purified from thymus or axillary and 
inguinal lymph nodes of  LIT2-37 x 37 HSA transgenic mice and normal, 
nontransgenic littermates by cell sorting, incubated in microtiter plate 
wells coated with CD3 mAb for 3 d and then pulsed with [3H]thymi- 
dine for 6 h. The data are from a single experiment, with standard devia- 
tions derived from four separate incubations of each cell sample. Similar 
proliferative responses were seen in all eight cell populations in three other 
independent experiments. However, the differences in the amounts of 
thymidine incorporation between different populations were not consis- 
tently seen in separate experiments, and therefore are not significant. In 
the absence of stimulating CD3 mAb, thymidine incorporation was <200 
cpm in all populations. cates that the limited number of mature T cells developing 
in the thymuses of the HSA transgenic mice were function- 
ally mature and did not have downstream defects in their 
abilities  to  transduce  signals  received  by  the  TCR-CD3 
complex. 
Discussion 
The introduction of a transgene directing high levels of 
HSA expression resulted in a severe defect in the production 
of T cells of the oe3-TCR lineage. Depletion of thymocytes 
in the HSA transgenic mice was first evident in early DP cells, 
as all thymocytes before this stage were unaffected and all 
thymocytes and T cells beyond this stage were depleted. It 
is possible that all of the depleting effects of the HSA trans- 
gene occur at the DP stage,  with the reduced numbers of 
SP thymocytes and peripheral T cells reflecting the previous 
elimination of most of their DP precursors. 
The onset of thymocyte depletion occurs just when the 
presence of the transgene is starting to override the progres- 
sive decline in HSA expression that normally accompanies 
the maturation of thymocytes. This implies that HSA acts 
quantitatively in restricting the ability of thymocytes to pass 
through the DP  stage  of their development. The human 
homolog of HSA, CD24 (29), can initiate the transduction 
of complex intracellular signaling, involving both calcium 
mobilization and tyrosine phosphorylation via the activation 
ofa CD24-associated tyrosine kinase (30, 31). Similar mech- 
anisms of signal transduction can presumably be initiated by 
HSA in thymocytes, and the escalation of such signaling by 
HSA overexpression  is a probable cause of the depletion of 
thymocytes in the transgenic mice. 
The defect in thymocyte development beyond the DN stage 
could be due to an inhibitory effect of abnormally high levels 
of HSA on proliferation. While SP cells and more mature 
DP cells are not dividing, there is proliferation of at least 
some immature DP cells (32, 33), and a suppression of their 
proliferative potential could result in the observed depletion 
in the numbers of these cells and their progeny in the HSA 
transgenic mice. However, such an effect would require that 
DP cells be uniquely sensitive to inhibition by HSA, as most 
DN cells are dividing despite their high levels of HSA ex- 
pression (33). 
The efficiency  of negative selection of thymocytes expressing 
oL3-TCR specific for self-antigens is a major determinant of 
the numerical output of thymocytes (34-36), and therefore 
the perturbation of this process could also explain the effects 
of HSA overexpression on thymocyte development. Mice ex- 
pressing TCR transgenes specific  for self-antigens have normal 
numbers of DN cells but greatly reduced numbers of DP 
and SP cells (34,  37, 38),  as a result of elimination of DP 
cells expressing the transgenic TCR. The timing and scale 
of thymocyte depletion resulting from negative selection of 
self-antigen-specific TCR in these transgenic mice are very 
similar to those seen in the HSA transgenic mice. Overex- 
pression of HSA in DP thymocytes could result in an increased 
probability of these cells undergoing negative selection, e.g., 
by escalating a secondary signal that lowers the threshold for 
apoptosis-inducing signals generated by the TCR-CD3 com- 
plex. There was a bias towards lower than normal TCR and 
CD3 expression levels among the limited numbers of DP and 
SP thymocytes that were found in the thymuses of the HSA 
transgenic mice, which would be expected if the threshold 
for TCR-derived signals mediating negative selection had been 
generally lowered. An amplifying effect on apoptosis-inducing 
signals from TCR has recently been described for Thy-1 (39), 
another  glycosyl  phosphadtidylinositol-linked protein ex- 
pressed on thymocytes. 
One discrepancy in the correlation between the cell types 
sensitive to HSA overexpression versus negative selection is 
that c~3-TCR + DN thymocytes (or their precursors) appear 
to be nonresponsive to negative selection in both normal and 
TCR transgenic mice (40-43), but these thymocytes were 
depleted in the HSA transgenic mice. a3-TCR + DN cells 
are normally distinguished from most thymocytes by their 
lack of HSA expression (44, 45), as well as by their apparent 
ability to evade negative selection. An intriguing possibility 
is that depletion of these cells in the HSA transgenic mice 
was due to their acquisition of susceptibility to negative se- 
lection as a consequence of overexpression  of HSA. 
Transgenic mice in which positive selection of thymocytes 
is eliminated by the expression of a TCR transgene specific 
for an inappropriate MHC have a phenotype that is quite 
distinct from that of the HSA transgenic mice, with normal 
numbers of DP  thymocytes but depleted numbers of SP 
thymocytes expressing the transgenic TCR (34, 37).  This 
difference indicates that overexpression of HSA is not deleting 
thymocytes by inhibiting positive selection of MHC-specific 
TCR., which appears to become a significant determinant of 
thymocyte numbers only in the late DP and SP stages. 
There is considerable evidence that HSA may be involved 
in regulating the antigen-dependent activation and differen- 
tiation of B cells. The subpopulation of primary B cells that 
express high levels of HSA are nonresponsive to proliferative 
signals provided by direct stimulation of their IgM antigen 
receptors (46), and are unable to form long-lasting memory 
B cells after exposure to antigen (8, 9). These HSA + B cells 
are capable of activation and differentiation into antibody- 
secreting cells with appropriate T cell help (46), which may 
be partially mediated by the presumptive HSA ligand/receptor 
expressed on Th cells. The responses of thymocytes to stim- 
ulation of their TCR antigen receptors may be similarly de- 
pendent on or modulated by HSA-derived signals, with con- 
sequent effects on their expansion versus deletion at the DP 
stage. It will be of great interest to determine exactly what 
processes in thymocyte development are affected by HSA, and 
to identify the source of the external  signals that stimulate 
HSA on thymocytes. 
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